Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD.

Stephen Caldwell Alnoor Ramji Tarek Hassanein Eric M Yoshida Emily Pang Caitlin Schneider Michael P Curry Nezam H Afdhal

Published in: Hepatology communications (2024)

Velacur was superior to FibroScan for liver fat detection with MRI-PDFF as the reference. Velacur and FibroScan were not statistically different for liver stiffness assessment as defined by magnetic resonance elastography.

Keyphrases

liver fibrosis
magnetic resonance
contrast enhanced
magnetic resonance imaging
adipose tissue
angiotensin ii
angiotensin converting enzyme
diffusion weighted imaging